Building on my experience in sales and marketing in healthcare, Health Insights Consulting Group helps healthcare and life sciences businesses of all sizes increase revenue through strategic review, market entry implementation, and revenue models focused on sustained growth. I also serve as an industry influencer for consulting firms on client engagements and private equity investors on portfolio investments. * Provide consulting engagements for Clario, General Inception, Triple Ring Technologies, Bain Capital, Foundation Asset Management, Mass Medical Angels, and Fleishman Hillard, including conducting M&A due diligence and evaluating potential investments. * Led consulting engagements for medical device start-ups Oped Medical, Q-Metrx, HealO, and Vascular Insights.* Provide advisory services for healthcare and medical device start-ups incubated at Advise Connect Inspire, MassChallenge, and German Accelerator Life Sciences.

I serve on the Board of Directors for Keyros Medica (ex REVINAX), founded in Montpellier, France, in 2015, addressing financing, operational, sales and marketing, compensation, and board governance challenges. Keyros Medica aims to be the leader in spatial-computing-based surgical training. It paves the path to becoming the primary resource for training humans and machines to operate, reducing time and errors, and improving global outcomes. Keyros Medica initially focused on developing first-person perspectives of real-life context medical interventions, using a patented device to capture in-situ (3D) from the perspective of the person performing them. Keyros Medica designed an extended reality software for delivering immersive tutorials and a deployment platform (including smartphones). Videogame content can be expensive to create and difficult to deploy; here is the scalable way to provide affordable immersive experiences that improve the customer experience and reduce the cost of serving customers while driving enhanced revenue generation.

I serve as Strategic Advisor to the Board of Directors for INIA Biosciences, based in Oxford, UK, and Boston, MA, addressing financing, operational, sales and marketing, compensation, and board governance challenges. INIA Biosciences aims to harness the power of sound waves to develop non-invasive, home-administered, and closed-loop medical devices to manage chronic inflammatory diseases to address the unmet needs of patients, providers, and payers.

As global Vice President, Marketing and Digital Strategy for Clario I led the organization's marketing function.• Led corporate and digital marketing, responsible for advertising, public relations, online marketing, product marketing, trade shows, event planning, marketing communications, and customer research. Developed and executed marketing strategy and plan to deliver a 10% year-over-year account and strategic partnership growth.• Designed organization and recruited 7 new Senior Directors responsible for channel and content strategies, campaign analytics and automation, digital creative services, website and marketing data governance, corporate brand and marketing technology strategy to drive best practices, tools, and processes for digital transformation across the enterprise.• Grew revenue from $900M to $1B by establishing a digital center of excellence in 6 months and enabling digital-first go-to-market strategies for new product launches, demand generation campaigns, and brand-building efforts. • In preparation for IPO, created a new brand strategy combining ERT and Bioclinica to form Clario and launched a new brand on target and budget within 12 weeks through the integrated campaign, including owned and paid channels. Led cross-functional team to define and deliver new positioning, value prop, brand architecture, tone of voice, segmented messaging, new website, and social strategy.Clario, a private equity-backed $1B global company, is the SaaS leader in technology and software solutions for clinical trial research. We fuse our deep scientific expertise and global scale into the broadest endpoint technology platform. By doing this, we empower our partners to transform lives.From planning a clinical trial through endpoint collection to database lock, we partner with our customers every step of the way to generate the rich evidence needed to bring medicines, medical devices, and other therapies to market.

Leading the digital marketing, creative services, and strategic brand management teams and a member of the BDX Marketing Leadership Team. I'm accountable for modernizing the Company’s digital marketing and strategic brand management capabilities, processes, platforms, and tools to drive commercial excellence, e-commerce, create competitive advantage, and accelerate sustainable, profitable growth. Focusing on spearheading the transformation of the central digital marketing and strategic brand management team, aligning investments to deliver impact across the increasingly complex and digitalized customer buying journey. I built a digital marketing center of excellence through the restructuring of existing resources and recruiting digital native talent for channel and content strategies, campaign analytics and automation, digital creative services, website and marketing data governance, and marketing technology strategy to drive best practices, tools, and processes for digital transformation across the enterprise. Created digital agile teams to respond globally to COVID-19. Specifically: implementation of Salesforce.com + Marketo integration for customer lead generation and ROI measurement; digital communications channels and platforms (e.g. Showpad for allowing sales force to communicate with customers in a scalable way); digital training platforms to educate customers on new rapid COVID-19 diagnostic products. Delivered future state omni-channel commercial transformation strategy that aligned to business goals and drivers. Specifically, delivered proposal and plan for seamless and intuitive enterprise-wide bd.com end-to-end experience that spans, pre-, during, and post-purchase and addresses customer pain points in the post-COVID world. Resulting in a revenue increase of $100M over 3 years, $7.6M in cost savings, and an ROI of 132%. Launched first-ever pandemic response brand campaign and narrative across owned and paid digital and social channels.

As Chief Digital Marketing and Operations Officer for GE Healthcare's global $19B businesses, I lead digital marketing strategy, digital implementation of enterprise-wide marketing initiatives, and marketing operations. The company was looking to improve customer engagement and brand loyalty through digital customer experiences. I restructured the existing 100+ person organization and hired new talent to help focus the organization on the importance of a holistic digital strategy and ecosystem, new technology stacks, and the importance of agile and scalable digital services delivery. To personalize experiences for customers across all stages of their lifecycle, launched a new digital ecosystem - MyGEHealthcare & Insights Hub. We increased unique visitors, onboarded 7,000+ customers, drove mobile engagement up by 28% and web leads by 16%, causing $13M in incremental revenue. Enabled 80+ new global digital-first product introductions, drove all GE Healthcare events and promotions inclusive of content development, digital activation, and marketing communications strategy to deliver commercial growth of 4% revenue, 6% profit, and 40bps margin in 2018. Without underpinning technology, we could not execute a digital customer experience. We utilized a digital marketing council responsible for streamlining our marketing technology stack, driving innovation, excellence, and execution in crucial challenge and gap areas to build the marketing stack. The result was the implementation of Allocadia for marketing budget planning and ROI measurement; content management via NewsCred; digital asset management with Widen; commercial sales enablement through Showpad and Salesforce.com and marketing automation through Marketo. To measure marketing content and campaigns end-to-end, we delivered the first-ever marketing ROI dashboard.

I served on the Board of Directors for Epsilon Imaging, Inc., founded in 2008, that utilizes technology spun out of the University of Michigan in Ann Arbor, MI. Developed in concert with leading echocardiography researchers and clinicians, Epsilon Imaging launched its flagship software platform, EchoInsight®, commercially in 2013. Designed to meet today’s challenges and transform cardiovascular management, EchoInsight assists to enhance quality and standardization, along with streamline analysis, interpretation and monitoring of echocardiography. Additionally, EchoInsight can assist institutional and cardiovascular program management with robust and standardized functional data analytics. Departure triggered by me joining GE Healthcare.

Responsible for company’s global marketing and sales strategy, operations and people, I led CASMED, an entrepreneurial company in the cerebral oximetry space, to 37% annual global growth in 2014. I also established the international distribution of the FORE-SIGHT ELITE cerebral oximeter into four countries (Japan, Germany, France and UK), resulting in 48% year over year sales growth in 2014.

As CMO for Philips Imaging Systems, I helped this $7B business capture $70M in incremental pricing year over year. I redefined the global marketing strategy across the Imaging unit's portfolio with an authentic marketing vision and go-to-market plan. Company was inefficiently managing six hundred marketing professionals spread over eight operating units around the world. I consolidated marketing function into four operating units with four hundred professionals. Result was an annual savings of $24M without a reduction in customer service or sales effectiveness. Division had reputation for producing products that were not selling as expected. I teamed with my R&D counterpart to provide voice of the customer insights. Kept R&D focused on the customer. Result was 5% market share increase in new Magnetic Resonance Imaging products and 3% market share increase in Computed Tomography products.

Led global Pain and Temperature management businesses following acquisitions with focus on key sales, marketing, strategic planning and product development functions.

In a series of increasing leadership roles, I helped transform Kimberly-Clark Health Care from $1B to $1.5B in revenues and make two acquisitions in the pain space: I-Flow and Baylis. This ultimately led to a successful spin-off of Kimberly-Clark Health Care as Halyard Health, an independent company with annual revenues of $1.6B. I created an opportunity to sustain and grow the $700 million surgical business with a disruptive business model in the custom procedural tray (CPT) space, and also delivered $30 million in annual cost reductions.

I served on the board of directors for SmartPill, an in-office method for assessing gastric motility, addressing financing, operational, sales and marketing, compensation and board governance issues.

I was hired especially to launch a new health care division (Rubbermaid Medical Solutions) focused on eMAR (Electronic Medication Administration Record), and delivered 56% gross margin and 41% operating income after successfully doing so. Today revenues for this business exceed $100M.

I led global strategic planning, product development and marketing for a $450 million business unit, and helped to manage a restructuring of Guidant Brazil to restored profitability within 12 months. I successfully launched new products, resulting in a market share increase of 8% for percutaneous coronary transluminal angioplasty (PTCA) and 20% for atherectomy.

After learning the business in sales/sales management from the ground up I was promoted to direct the company’s global product development and domestic marketing of percutaneous transluminal angioplasty (PTA) – a $100M franchise with 10 brands and over 1,000 skus, the largest franchise in the entire company.

I launched the new DeWalt Power Tool Company in the home centers and warehouse home centers channel, increasing national market share by 16 points focusing on The Home Depot as a strategic opportunity, and our sales increased from $9.5M to $28M in the first year. Today DeWalt Power Tool Company has revenues eclipsing $2B in annual revenues.